China has administered over 31 million doses of COVID-19 vaccines
Share - WeChat
China has administered over 31 million doses of COVID-19 vaccines for key groups as of Wednesday.
China granted conditional market approval for its first COVID-19 vaccine on Dec 30, but vaccines in the last stage of clinical trials have been available for emergency use in the country since June. By the end of December, 14 COVID-19 vaccines developed by China were under clinical trials, including five in phase 3, the final trial before a vaccine is approved for market.
The inactivated COVID-19 vaccine, developed by State-owned Sinopharm, which won conditional market approval, is safe and has an efficacy of 79 percent, the company said.
- US defense policy act fuels Taiwan tensions
- New Year holiday to bring peak in travel
- China's top 10 sci-tech news events unveiled
- Over 700 generative AI large model products complete filing in China
- Beijing accuses Lai of 'kowtowing' to US
- Hong Kong's global standing boosted with increasing presence of intl organizations: justice secretary
































